We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Duloxetine Induced Hyponatremia.
- Authors
ŞAHAN, Ebru; PARLAKKAYA YILDIZ, Fatma Büşra
- Abstract
Hyponatremia can be asymptomatic or have a wide range of clinical presentations such as headaches, muscle cramps, nausea, seizures, coma, cerebral edema and may even result in death. Despite it has been suggested that duloxetine has a relatively less risk of hyponatraemia, the number of case reports are increasing. A 45-year old female patient with complaints of fear, anxiety, sleeplessness and headache was started on duloxetine (30 mg/day). In the first week of the treatment, she was admitted to the emergency service with dizziness, dry mouth, polyuria and polydipsia. She had to be transferred to the intensive care unit because of agitation, loss of consciousness and a generalized tonic-clonic seizure. Blood levels of Sodium (Na+), Potassium (K+) and Chlorine (Cl-) were, respectfully, 121 mmol/L, 2.7 mmol/L and 87 mmol/L. Brain imaging displayed cerebral edema. Electrolyte levels were regulated with saline infusions. Amitriptyline was initiated for the ongoing headache and anxiety. In outpatient visits, hyponatremia did not recur in the following 3 months. Low dose duloxetine was associated with severe hyponatremia signs and symptoms in an individual who was not previously considered as high risk for hyponatraemia. The patient's history did not reveal any complaints related to hyponatremia when she was treated with sertraline two years ago. Based on these, we discussed the risk factors for hyponatremia and risky antidepressant classes.
- Subjects
LOSS of consciousness; HYPONATREMIA; SYMPTOMS; MUSCLE cramps; CEREBRAL edema; INTENSIVE care units; SEIZURES (Medicine)
- Publication
Turkish Journal of Psychiatry, 2019, Vol 30, Issue 4, p1
- ISSN
1300-2163
- Publication type
Article
- DOI
10.5080/u23394